bf/NASDAQ:EXEL_icon.jpeg

COM:EXELIXIS

Exelixis

  • Stock

USD

Last Close

34.83

22/11 21:00

Market Cap

6.42B

Beta: -

Volume Today

1.68M

Avg: -

Company Overview

Metric
Company NameExelixis, Inc.FiercePharmaXynomic Pharmaceuticals Holdings, Inc.
SymbolEXEL
MSH IDCOM:EXELIXISCOM:FIERCEPHARMACOM:XYNOMICPHARMA
MarketSTOCKSPRIVATEPRIVATE
SectorHealthcareCommercial & Professional ServicesHealthcare & Health Services
IndustryBiotechnologyPharmaceuticalsPharmaceuticals
CountryUSUSUS
StageSeries B
Employee Count1.31K
Websiteexelixis.comfiercepharma.comxynomicpharma.com
LinkedIn
Founders

Market Metrics

Metric
Market Cap6.42B
Enterprise Value
Monthly Web Traffic484.53K1.52K
Web Traffic Growth-0.104.19
Valuation
Raised Capital

Financial Performance

Metric
Revenue1.83B
Revenue (LTM)
Revenue (NTM)
Gross Profit1.76B
EBITDA196.60M
Operating Income170.88M
Net Income207.76M
EPS0.65
Diluted EPS0.65
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Profitability Ratios

Metric
Gross Profit Margin0.97
Operating Profit Margin0.18
EBITDA Margin0.11
Net Profit Margin0.17
Return on Equity0.16
Return on Assets0.13
Return on Capital Employed0.15

Valuation Multiples

Metric
P/E Ratio73.55
P/B Ratio2.88
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio4.16
EV Multiple41.14

Operational Metrics

Metric
Days Sales Outstanding51.04
Days Payables Outstanding144.71
Days Inventory Outstanding132.29
Operating Cycle193.66
Cash Conversion Cycle36.85
Asset Turnover0.73

Cash Flow Metrics

Metric
Operating Cash Flow333.32M
Free Cash Flow170.35M
Cash Flow to Debt1.61
Operating Cash Flow/Sales0.18
Free Cash Flow Yield0.03

Balance Sheet Metrics

Metric
Cash & Equivalents262.99M
Accounts Receivable-22.62M
Inventory17.32M
Goodwill63.68M
Debt to Capitalization0.09
Debt to Assets
Current Ratio3.83
Quick Ratio4.21

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue0.06
R&D to Revenue0.64
SG&A to Revenue